Back to Cubist Systematic Strategies, LLC Cubist Systematic Strategies, LLC

EGRXEGRX
25 quarters

Position history for Cubist Systematic Strategies, LLCCubist Systematic Strategies, LLC's holdings in EAGLE PHARMACEUTICALS INC

Cubist Systematic Strategies, LLC previously held 0 shares of EGRX (EAGLE PHARMACEUTICALS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$947,000

Total Shares Change

-23,506

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
6,152
-76.2%
$22,9470.0%$3.95
0
2024-Q2
New
25,812
-
$144,5460.0%$5.60
31
2024-Q1
Exited
0
-100.0%
$00.0%$5.24
0
2023-Q4
Decreased
15,228
-74.0%
$79,6420.0%$5.23
0
2023-Q3
Decreased
58,531
-21.4%
$923,0350.0%$15.77
0
2023-Q2
Increased
74,508
+95.7%
$1.4M0.0%$19.47
41
2023-Q1
Increased
38,068
+515.3%
$1.1M0.0%$27.88
41
2022-Q4
New
6,187
-
$180,8460.0%$29.23
31
2022-Q3
Exited
0
-100.0%
$00.0%$28.60
0
2022-Q2
Decreased
9,658
-23.8%
$429,0000.0%$43.12
0
2022-Q1
Increased
12,679
+52.3%
$627,0000.0%$49.50
34
2021-Q4
Decreased
8,323
-34.4%
$424,0000.0%$51.10
0
2021-Q3
Increased
12,680
+52.1%
$707,0000.0%$55.09
34
2021-Q2
Decreased
8,334
-47.9%
$357,0000.0%$42.14
0
2021-Q1
Increased
16,001
+86.1%
$668,0000.0%$41.06
38
2020-Q4
Increased
8,600
+46.6%
$401,0000.0%$46.50
33
2020-Q3
New
5,866
-
$249,0000.0%$41.88
32
2020-Q2
Exited
0
-100.0%
$00.0%$48.02
0
2020-Q1
New
5,463
-
$251,0000.0%$45.31
32
2019-Q4
Exited
0
-100.0%
$00.0%$59.89
0
2019-Q3
Decreased
5,862
-32.4%
$332,0000.0%$56.43
0
2019-Q2
Increased
8,677
+2.5%
$483,0000.0%$55.68
25
2019-Q1
Decreased
8,463
-64.0%
$427,0000.0%$50.49
0
2018-Q4
New
23,506
-
$947,0000.0%$39.23
35

Other major holders of EGRX: BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used